Keyword

PCV13

Description: A 13-valent pneumococcal conjugate vaccine used to stimulate immunity against thirteen serotypes of Streptococcus pneumoniae.

Primary topic: Pneumonia and Respiratory Infections (87%)

Wikidata ID: wiki/Q7205991

OpenAlex ID: keywords/pcv13

Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults

2015 · Marc J.M. Bonten, Susanne M. Huijts, et al. · New England Journal of Medicine · 1,239

PDF

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

2015 · Matthew R Moore, Ruth Link-Gelles, et al. · The Lancet Infectious Diseases · 733

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study

2015 · Pauline A Waight, Nicholas J Andrews, et al. · The Lancet Infectious Diseases · 588

PDF

Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study

2018 · Shamez N Ladhani, Sarah Collins, et al. · The Lancet Infectious Diseases · 561

PDF

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study

2014 · Nick J Andrews, Pauline A Waight, et al. · The Lancet Infectious Diseases · 542

Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis

2017 · Evelyn Balsells, Laurence Guillot, et al. · PLoS ONE · 393

PDF

Effects of Vaccination on Invasive Pneumococcal Disease in South Africa

2014 · Anne von Gottberg, Linda de Gouveia, et al. · New England Journal of Medicine · 373

PDF

Impact of 13-Valent Pneumococcal Conjugate Vaccination in Invasive Pneumococcal Disease Incidence and Mortality

2014 · Zitta Barrella Harboe, Tine Dalby, et al. · Clinical Infectious Diseases · 313

PDF

Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study

2019 · Stephanie W Lo, Rebecca A Gladstone, et al. · The Lancet Infectious Diseases · 292

PDF

Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010.

2010 · PubMed · 258

Trends in Otitis Media–Related Health Care Use in the United States, 2001-2011

2013 · Tal Marom, Alai Tan, et al. · Archives of Pediatrics and Adolescent Medicine · 233

Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis

2016 · Tinevimbo Shiri, Samik Datta, et al. · The Lancet Global Health · 223

PDF

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A

2011 · David Cooper, Xinhong Yu, et al. · Vaccine · 223

Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

2015 · Miwako Kobayashi, Nancy M Bennett, et al. · MMWR Morbidity and Mortality Weekly Report · 219

Pediatric Invasive Pneumococcal Disease in the United States in the Era of Pneumococcal Conjugate Vaccines

2012 · Tina Q. Tan · Clinical Microbiology Reviews · 205

Review: Current and new generation pneumococcal vaccines

2014 · Charles Feldman, Ronald Anderson · Journal of Infection · 196

PDF

Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis

2014 · Lone Simonsen, Robert J Taylor, et al. · The Lancet Respiratory Medicine · 195

Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study

2016 · Matthew R Moore, Ruth Link-Gelles, et al. · The Lancet Respiratory Medicine · 194

Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study

2016 · Grant A Mackenzie, Philip C Hill, et al. · The Lancet Infectious Diseases · 179

PDF

Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years

2021 · Brandon Essink, Charu Sabharwal, et al. · Clinical Infectious Diseases · 174

PDF

Pneumococcal serotype evolution in Western Europe

2015 · Myint Tin Tin Htar, Dina Christopoulou, et al. · BMC Infectious Diseases · 167

PDF

Near-Elimination of Otitis Media Caused by 13-Valent Pneumococcal Conjugate Vaccine (PCV) Serotypes in Southern Israel Shortly After Sequential Introduction of 7-Valent/13-Valent PCV

2014 · Shalom Ben-Shimol, Noga Givon-Lavi, et al. · Clinical Infectious Diseases · 166

Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination

2018 · Germaine Hanquet, Pavla Krizova, et al. · Thorax · 164

PDF

Changes in Pneumococcal Serotypes and Antimicrobial Resistance after Introduction of the 13-Valent Conjugate Vaccine in the United States

2014 · Sandra S. Richter, Daniel J. Diekema, et al. · Antimicrobial Agents and Chemotherapy · 159

PDF

Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden

2016 · Ilias Galanis, Ann Lindstrand, et al. · European Respiratory Journal · 155

PDF

Works count: 3,337

Citation count: 45,870